Finland· FI-REL-REL705

Pimafucort

A hydrocortison und antibiotika product containing natamycin + hydrocortisone + neomycin sulfate, registered in Finland by Yamanouchi Europe B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC D07CA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedPimafucortATCD07CA01REGISTER NO.FI-REL-REL705PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Hydrocortison und antibiotika is registered in 10 of 19 countries.

Countries holding a registration under ATC D07CA01 (hydrocortison und antibiotika), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose

Hydrocortison und antibiotika · ATC D07CA01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Natamycin + Hydrocortisone + Neomycin sulfate
Manufacturer
Yamanouchi Europe B.V.
Country
Finland (FI)
ATC code
D07CA01
ATC class
Hydrocortison und Antibiotika
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hydrocortison und antibiotika in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydrocortison und antibiotika products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Czechia · Pimafucort
  • Hungary · Pimafucort
  • Netherlands · Pimafucort
  • Poland · Pimafucort

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed11ecd8-83b3-489d-b26d-a4a8e7d95818
GET /v1/drugs/ed11ecd8-83b3-489d-b26d-a4a8e7d95818?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "linimentti",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "hydrokortisoni ja antibiootit",
  "ma_number": "5756",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL705",
  "authorised_at": "1969-04-30"
}

See everything about hydrocortison und antibiotika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.